Daycare chemotherapy services launched at Government Wenlock Hospital and District Government Hospital in Mangaluru and Udupi ...

Aubrey Barnett, 17, graduated from Walnut Grove High School just five months after finishing chemotherapy and ringing the ...

In an interview, Aditya Shreenivas, MD, MS, discussed the approval of penpulimab in nasopharyngeal carcinoma and the study ...

After meeting the mark alongside Keytruda in PD-L1-positive breast cancer earlier this year, Gilead Sciences' antibody-drug ...

King Charles was diagnosed with cancer in February 2024, following treatment for an enlarged prostate. Since then, he has ...

Treatment with retifanlimab plus carboplatin-paclitaxel statistically significantly reduced the risk of progression or death by 37% compared with placebo plus carboplatin-paclitaxel.

Mature overall survival results of the INAVO120 trial were presented in a press conference for the American Society of ...

Gilead Sciences (NASDAQ:GILD) announced Friday that its antibody-drug conjugate Trodelvy reached the main goal compared to ...

In an interview, Prof Martin Dreyling discussed the approval of first-line acalabrutinib for the treatment of adult patients ...

Depending on tumor location, presurgical radiation can improve overall survival, but that option comes with an increased risk ...

Carolyn Collins endured two decades of treatment. Now cancer-free, she reflects on her journey of faith and perseverance.

Chemotherapy — often called “chemo” — can be difficult on the body, including the heart. “Cancer therapies can cause a broad ...